Latest Advances

  • Journal: Mymensingh medical journal : MMJ
  • Published —
Value of Serum Adenosine Deaminase (ADA) in Distinguishing between Tuberculous and Non-tuberculous Lymphadenopathies.
  • Journal: In vivo (Athens, Greece)
  • Published —
Paraneoplastic Intrahepatic Cholestasis in Supradiaphragmatic Classical Hodgkin Lymphoma Successfully Treated With Brentuximab Vedotin: A Case Report and Review of the Literature.
  • Journal: European review for medical and pharmacological sciences
  • Published —
Is classical Hodgkin lymphoma a different disease in the elderly? A single-center retrospective cohort study.
  • Condition: Sintilimab-Induced Diabetic Ketoacidosis (DKA) in Patient with Small Cell Lung Cancer
  • Journal: Medicine
  • Treatment Used: Insulin Therapy, Sintilimab Discontinuation and Conversion to Durvalumab
  • Number of Patients: 1
  • Published —
This case report describes a 59-year-old man with small cell lung cancer diagnosed with sintilimab-induced diabetic ketoacidosis treated with insulin therapy, sintilimab discontinuation and conversion to durvalumab.
  • Journal: The Lancet. Haematology
  • Published —
PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trial.
  • Journal: The Lancet. Haematology
  • Published —
Brentuximab vedotin with chemotherapy for stage III or IV classical Hodgkin lymphoma (ECHELON-1): 5-year update of an international, open-label, randomised, phase 3 trial.
  • Journal: The Lancet. Haematology
  • Published —
Camidanlumab tesirine in patients with relapsed or refractory lymphoma: a phase 1, open-label, multicentre, dose-escalation, dose-expansion study.
  • Journal: Orphanet journal of rare diseases
  • Published —
Lymphoproliferative malignancies in patients with neurofibromatosis 1.
  • Journal: Annals of hematology
  • Published —
PET/MRI for staging patients with Hodgkin lymphoma: equivalent results with PET/CT in a prospective trial.
  • Condition: Hodgkin's Lymphoma (HL)
  • Journal: Upsala journal of medical sciences
  • Treatment Used: Radiotherapy
  • Number of Patients: 0
  • Published —
This study initiated an intervention study to decrease morbidity and mortality of cardiovascular disease (CVD) in patients with Hodgkin's lymphoma (HL).
  • Condition: Relapsed or Refractory (R/R) Classical Hodgkin Lymphoma (cHL)
  • Journal: European review for medical and pharmacological sciences
  • Treatment Used: Brentuximab Vedotin (BV) after Autologous Stem Cell Transplantation (ASCT)
  • Number of Patients: 383
  • Published —
This study examined the overall survival (OS) and progression-free survival (PFS) in patients with relapsed (recurring) or refractory (resistant to treatment) classical Hodgkin lymphoma (a cancer of the lymphatic system; cHL) treated with brentuximab vedotin (BV) after autologous stem cell transplantation (stem cells are removed from a person, stored, and later given back to that same person; ASCT).
  • Journal: Journal of medical case reports
  • Published —
Composite lymphoma of T-cell rich, histiocyte-rich diffuse large B-cell lymphoma and nodular lymphocyte predominant Hodgkin lymphoma: a case report.
Showing 1-12 of 147